» Articles » PMID: 30787438

β-Synuclein-reactive T Cells Induce Autoimmune CNS Grey Matter Degeneration

Abstract

The grey matter is a central target of pathological processes in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. The grey matter is often also affected in multiple sclerosis, an autoimmune disease of the central nervous system. The mechanisms that underlie grey matter inflammation and degeneration in multiple sclerosis are not well understood. Here we show that, in Lewis rats, T cells directed against the neuronal protein β-synuclein specifically invade the grey matter and that this is accompanied by the presentation of multifaceted clinical disease. The expression pattern of β-synuclein induces the local activation of these T cells and, therefore, determined inflammatory priming of the tissue and targeted recruitment of immune cells. The resulting inflammation led to significant changes in the grey matter, which ranged from gliosis and neuronal destruction to brain atrophy. In humans, β-synuclein-specific T cells were enriched in patients with chronic-progressive multiple sclerosis. These findings reveal a previously unrecognized role of β-synuclein in provoking T-cell-mediated pathology of the central nervous system.

Citing Articles

The neuroimmune connectome in health and disease.

Wheeler M, Quintana F Nature. 2025; 638(8050):333-342.

PMID: 39939792 DOI: 10.1038/s41586-024-08474-x.


CSF synaptic biomarkers and cognitive impairment in multiple sclerosis.

Barba L, Gaetani L, Sperandei S, Di Sabatino E, Abu-Rumeileh S, Halbgebauer S J Neurol. 2024; 272(1):85.

PMID: 39708160 PMC: 11663154. DOI: 10.1007/s00415-024-12851-x.


PINK1 is a target of T cell responses in Parkinson's disease.

Williams G, Freuchet A, Michaelis T, Frazier A, Tran N, Rodrigues Lima-Junior J J Clin Invest. 2024; 135(4).

PMID: 39688918 PMC: 11827839. DOI: 10.1172/JCI180478.


Mitochondrial calcium uniporter complex controls T-cell-mediated immune responses.

Shumanska M, Lodygin D, Gibhardt C, Ickes C, Stejerean-Todoran I, Krause L EMBO Rep. 2024; 26(2):407-442.

PMID: 39623165 PMC: 11772621. DOI: 10.1038/s44319-024-00313-4.


Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.

Kalia L, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca D Nat Rev Neurol. 2024; 20(12):724-737.

PMID: 39375563 DOI: 10.1038/s41582-024-01023-0.


References
1.
Smith L, Kono D, Theofilopoulos A . Complexity and sequence identification of 24 rat V beta genes. J Immunol. 1991; 147(1):375-9. View